• Prestained Protein Marker: SDS-PAGE Guide

  2026-09-21

  This Prestained Protein Marker provides visible size landmarks from 10–250 kDa for monitoring SDS-PAGE separation and checking Western blot transfer. It is appropriate for denaturing gel and membrane workflows, including EDTA-sensitive Phosbind and fluorescent imaging applications, but it should not be used as a substitute for protein identity, purity, or exact mass confirmation.

• RRP Restores Lipid Metabolism in HIRI

  2026-09-21

  The reference study shows that Radix Rehmanniae Praeparata extracts protect against hepatic ischemia-reperfusion injury by correcting cholesterol synthesis and efflux rather than acting only as general hepatoprotective agents. Its mouse and hepatocyte experiments connect AMPK activation and mTOR inhibition with suppression of SCAP-SREBP2 processing, enhanced LXRα activity, and improved lipid handling.

• Ceapin-A7 in ER Stress-to-Pyroptosis Research

  2026-09-20

  Ceapin-A7 is a selective ER stress blocker for separating ATF6α signaling from PERK-driven inflammatory death. This article translates recent nucleus pulposus cell findings into a rigorous assay strategy for endoplasmic reticulum stress research.

• Ibrexafungerp Against Echinocandin-Resistant Candida

  2026-09-19

  This study evaluated Ibrexafungerp, also known as MK 3118, against 192 clinically derived Candida isolates with phenotypic or genotypic echinocandin resistance. Its mutation-resolved analysis shows retained activity overall, but susceptibility varied by species and by the position of FKS hotspot mutations, providing a more precise view of possible cross-resistance.

• MAPK10–KRT16 Control of NSCLC Metastasis

  2026-09-19

  The reference study identifies a phosphorylation-dependent MAPK10–KRT16–RNF213 pathway that promotes KRT16 ubiquitination and proteasomal degradation, thereby restraining non-small cell lung cancer metastasis. Its combination of molecular, functional, animal, and clinical analyses supports this axis as a candidate prognostic framework while leaving important questions about therapeutic specificity and clinical validation.

• (R)-MG132: A Rigorous Proteasome Control

  2026-09-18

  Explore how (R)-MG132, the MG-132 enantiomer, strengthens proteasome inhibition validation in metabolic and cancer-cell studies. This article presents a practical control strategy using the HNRNPU lactylation–PHGDH axis as a case study in separating proteasome-dependent effects from experimental artifacts.

• Ibotenic Acid Toxicity in Mice: Dose and Time

  2026-09-17

  A 2026 murine study provides a time-resolved analysis of Ibotenic acid toxicity, linking exposure level to behavioral changes, biochemical disruption, early c-fos activation, and reduced Nissl bodies. Its findings help distinguish reversible acute responses from severe neurotoxic injury and inform the design of safer neuroscience experiments and neurodegenerative disease models.

• ABT-888 (Veliparib): From Repair Biology to Translation

  2026-09-17

  A translational perspective on how ABT-888 (Veliparib) can be used to interrogate PARP1/2-dependent DNA repair, chemotherapy and radiation sensitization, and biomarker-driven combination strategies—while recognizing that DNA damage response dependencies are context specific.

• FAISL–FAK Regulation in Triple-Negative Breast Cancer

  2026-09-16

  The reference study identifies FAISL as a long noncoding RNA that stabilizes focal adhesion kinase by preventing Calpain 2-mediated proteolysis, thereby promoting aggressive triple-negative breast cancer behavior. Its combination of RNA–protein interaction analysis, mechanistic cell assays, patient-data correlation, and nanoparticle siRNA delivery reveals a regulatory route that extends beyond direct FAK kinase inhibition.

• VE-822 ATR Inhibitor: Workflow & Troubleshooting

  2026-09-16

  Build reproducible ATR-inhibition experiments with VE-822, from DMSO handling and dose scheduling to radiation and gemcitabine combination assays. The workflow also shows how the compound can be used to connect replication-stress biology with emerging nuclear cGAS and genome-integrity research.

• PP 2 (AG 1879) for Src-FAK Signaling

  2026-09-15

  PP 2 (AG 1879) gives researchers a practical way to separate Src-family kinase activity from downstream cytoskeletal, invasion, and immune-signaling effects. This workflow connects cancer research and T cell assays with a newer application in phosphatidic acid–driven decidualization while emphasizing controls, stock handling, and endpoint selection.

• Magnetic Nano-Antibodies Enable In Vivo CAR-T Mimicry

  2026-09-15

  The Advanced Materials study introduces M-BiNanoAb, a magnetic bispecific nano-antibody that recruits circulating T cells, gives them CAR-T-like tumor-recognition properties, and directs them toward solid tumors with an external magnetic field. Its main significance is a non-genetic, spatially guided strategy for addressing poor tumor infiltration without conventional ex vivo CAR-T manufacturing.

• KU-60019: Evidence-Driven ATM Assay Design

  2026-09-14

  KU-60019 is a selective ATM kinase inhibitor for dissecting DNA damage response signaling, glioma radiosensitization, and invasion phenotypes. This article adds an evidence-driven assay framework that separates pathway inhibition from downstream cellular and viral readouts.

• (±)-Blebbistatin for Spatial Cell Mechanics

  2026-09-14

  Use (±)-Blebbistatin as a reversible perturbation of non-muscle myosin II to connect cell force generation with migration, adhesion, and morphology. A spatially registered workflow, inspired by multimodal cardiac mapping, improves dose selection and separates local cytoskeletal responses from imaging or culture artifacts.

• Cyclopamine: Hedgehog Signaling Inhibitor Workflows

  2026-09-13

  Cyclopamine enables controlled Smoothened inhibition across cancer-cell, pathway, and developmental biology experiments. This workflow-centered guide connects concentration selection, orthogonal apoptosis assays, APOC1-focused thyroid cancer research, and troubleshooting to help researchers obtain interpretable results.

7959 records 1/531 page Next 12345 下5页 Last page